Scientific Publications

Peer-reviewed Scientific Articles

Devices & Systems Biology

Integrated Gut/Liver Microphysiological Systems Elucidates Inflammatory Inter-Tissue Crosstalk

Chen, W. L., Edington C., Suter E., Yu J., Velazquez J. G., Shockley M., Large E. M., Venkataramanan R., Hughes D. J., Stokes C. L., Trumper D. L., Carrier R. L., Cirit M., Griffith L. G. & Lauffenburger D. A. .
Biotechnology and Bioengineering, 2017; 114(11):2648-2659.

doi: 10.1002/bit.26370.

Opportunities and Challenges in the wider adoption of liver and interconnected microphysiological systems

Hughes, D. J., Kostrzewski T. & Sceats, E. L.
Experimental Biology & Medicine, 2017; 242(16):1593-1604.

doi: 10.1177/1535370217708976.

Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS)

Maass C., Stokes C. L., Griffith L. G. & Cirit, M.
Integr. Biol., 2017; 9(4):290-302.

doi: 10.1039/c6ib00243a.

Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration

Yu, J., Clifone N. A., Large E. M., Sarkar U., Wishnok J. S., Tannenbaum S. R., Hughes D. J., Lauffenburger D. A., Griffith L., Stokes C. L. & Cirit M.
CPT: pharmacometrics & systems pharmacology, 2015; 4, 585-594.

doi: 10.1002/psp4.12010.

Bioreactor technologies to support liver function in vitro

Ebrahimkhani, M., Neiman, J., Raredon, M., Hughes, D. & Griffith, L.
Advanced Drug Delivery Reviews, 2014; 69–70, 132-157.

doi: 10.1016/j.addr.2014.02.011.

Perfused multiwell plate for 3D liver tissue engineering.

Domansky K., Inman W., Serdy J., Dash A., Lim M. H. & Griffith, L. G
Lab on a chip, 2010 10 (1), 51-8.

doi: 10.1039/b913221j.

Design, modeling and fabrication of a constant flow pneumatic micropump

Walker, I. et al.
Journal of Micromechanics and Microengineering, 2007; 17 (5), 891.

Pharmacokinetics Drug Metabolism & Toxicology

Perfused human hepatocyte microtissues identify reactive metabolite-forming and mitochondria-perturbing hepatotoxins

Rowe C., Shaeri M., Large E. M., Cornforth T., Robinson A., Kostrzewski T., Sison-Young R., Goldring C., Park K. & Hughes D. J.
Toxicology in Vitro, 2018; 46:29-38.

doi: 10.1016/j.tiv.2017.09.012.

Integrated assessment of diclofenac biotransformation, pharmacokinetics, and omics-based toxicity in a 3D human liver-immunocompetent co-culture system

Sarkar U., Ravindra K. C., Large E., Young C. L., Rivera-Burgos D., Yu J., Cirit M., Hughes D. J., Wishnok J. S., Lauffenburger D. A., Griffith L. G, Tannenbaum SR.
Drug Metabolism and Disposition, 2017; 45 (7) 855-866.

doi: 10.1124/dmd.116.074005.

Quantitative Assessment of Population Variability in Hepatic Drug Metabolism Using a Perfused Three-Dimensional Human Liver Microphysiological System

Tsamandouras N., Kostrzewski T., Stokes C. L., Griffith L. G., Hughes D. J. & Cirit M.
J Pharmacol Exp Ther, 2017; 360(1): 95-105 [PMID: 27760784

Modeling Therapeutic Antibody-Small Molecule Drug-Drug Interactions Using a Three-Dimensional Perfusable Human Liver Coculture Platform.

Long T. J., Cosgrove P. A., Dunn R. T., Stolz D. B., Hamadeh H., Afshari C., McBride H. & Griffith L. G.
Drug Metab Dispos 2016; 44(12): 1940-1948 [PMID: 27621203 PMCID: PMC5118635

Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device.

Vivares A., Salle-Lefort S., Arabeyre-Fabre C., Ngo R., Penarier G., Bremond M., Moliner P., Gallas J. F., Fabre G. & Klieber S.
Xenobiotica, 2015; 45(1): 29-44

doi: 10.3109/00498254.2014.944612.

Metabolite Profiling and Pharmacokinetic Evaluation of Hydrocortisone in a Perfused Three-Dimensional Human Liver Bioreactor

Sarkar U., Rivera-Burgos D., Large E. M., Hughes D. J., Ravindra K. C., Dyer R. L., Ebrahimkhani M. R., Wishnok J. S., Griffith L. G. & Tannenbaum S. R.
Drug Metabolism and Disposition, 2015; 43, 1091-1099.

doi: 10.1124/dmd.115.063495.

Disease Models

A Microphysiological System for Studying Nonalcoholic Steatohepatitis

Kostrzewski T., Maraver P., Ouro‐Gnao L., Levi A., Snow S., Miedzik A., Rombouts K. & Hughes D.

Hepatology Communications, 2019.

doi: 10.1002/hep4.1450

3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection

Ortega-Prieto A. M., Skelton J. K., Wai S. N., Large E., Lussignol M., Vizcay-Barrena G., Hughes D, Fleck R. A., Thursz M., Catanese M. T. & Dorner M.
Nature Communications 2018; 14;9(1):682.

doi: 10.1038/s41467-018-02969-8.

Integrated Gut/Liver Microphysiological Systems Elucidates Inflammatory Inter-Tissue Crosstalk

Chen, W. L., Edington C., Suter E., Yu J., Velazquez J. G., Shockley M., Large E. M., Venkataramanan R., Hughes D. J., Stokes C. L., Trumper D. L., Carrier R. L., Cirit M., Griffith L. G. & Lauffenburger D. A. .
Biotechnology and Bioengineering, 2017; 114(11):2648-2659.

doi: 10.1002/bit.26370.

Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease

Kostrzewski T., Cornforth T., Snow S. A., Ouro-Gnao L., Rowe C., Large E. M. & Hughes D. J.
World Journal of Gastroenterology 2017; 23(2): 204-215

doi: 10.3748/wjg.v23.i2.204.

Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system

Wheeler S. E., Clark A. M., Taylor D. P., Young C. L., Pillai V. C., Stolz D. B., Venkataramanan R., Lauffenburger D., Griffith L. & Wells A.
Br J Cancer 2014; 111(12): 2342-2350 [PMID: 25314052 PMCID: PMC4264444

doi: 10.1038/bjc.2014.533.

Multi-Organ Systems

Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies

Tsamandouras N., Chen W. L. K., Edington C. D., Stokes C. L., Griffith L. G. & Cirit M.
AAPS J, 2017; 19: 1499.

doi: 10.1208/s12248-017-0122-4

Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies

Maass C., Dallas M., LaBarge M. E., Shockley M., Valdez J., Geishecker E., Stokes C. L., Griffith L. G. & Cirit M.
Scientific Reports, 2018; 8(1):8015.

doi: 10.1038/s41598-018-25971-y.

Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies

Edington C. D., Chen W. L. K., Geishecker E., Kassis T., Soenksen L. R., Bhushan B. M., Freake D. , Kirschner J., Maass C., Tsamandouras N., Valdez J., Cook C. D., Parent T., Snyder S., Yu J., Suter E., Shockley M., Velazquez J., Velazquez J. J., Stockdale L., Papps J. P., Lee I., Vann N., Gamboa M., LaBarge M. E., Zhong Z., Wang X., Boyer L. A., Lauffenburger D. A., Carrier R. L., Communal C., Tannenbaum S. R., Stokes C. L., Hughes D. J., Rohatgi G., Trumper D. L., Cirit M. & Griffith L. G.
Nature Scientific Reports, 2018; 4;8(1):4530.

doi: 10.1038/s41598-018-22749-0.

Integrated Gut/Liver Microphysiological Systems Elucidates Inflammatory Inter-Tissue Crosstalk

Chen, W. L., Edington C., Suter E., Yu J., Velazquez J. G., Shockley M., Large E. M., Venkataramanan R., Hughes D. J., Stokes C. L., Trumper D. L., Carrier R. L., Cirit M., Griffith L. G. & Lauffenburger D. A. .
Biotechnology and Bioengineering, 2017; 114(11):2648-2659.

doi: 10.1002/bit.26370.

Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS)

Maass C., Stokes C. L., Griffith L. G. & Cirit, M.
Integr. Biol., 2017; 9(4):290-302.

doi: 10.1039/c6ib00243a.

Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration

Yu, J., Clifone N. A., Large E. M., Sarkar U., Wishnok J. S., Tannenbaum S. R., Hughes D. J., Lauffenburger D. A., Griffith L., Stokes C. L. & Cirit M.
CPT: pharmacometrics & systems pharmacology, 2015; 4, 585-594.

doi: 10.1002/psp4.12010.

Scientific Conference Poster Presentations

The PNPLA3 I148 variant enhances the disease phenotype of hepatic stellate cells in an in vitro model of non-alcoholic fatty liver disease

Tomasz Kostrzewski, Paloma Maraver, Sophie Snow, Ana Levi, Kareene Smith, Krista Rombouts and David Hughes

Size 2 MB

Multi-organ in vitro Organ-On-Chip models for intestinal drug absorption and metabolism

Alysha Bray, Dharaminder Singh, Kareene Smith, David Hughes, Tomasz Kostrzewski

Size 2 MB

Comparing an in vitro Organ-on-Chip model of Non-Alcoholic Steatohepatitis to murine models and liver tissue from patients

Tomasz Kostrzewski, Sophie Snow, Anya Lindstrom Battle, Samantha Peel, Zahida Ahmad, Jayati Basak, Daniel Lindén, Christian Maass, Andrzej Kierzek, Kareene Smith, Piet van der Graaf, Lorna Ewart and David Hughes.

Size 2 MB

The Characterisation of a Human Two Organ-on-a-Chip (Lung-Liver) System which has the Potential to Measure Systemic Responses In Vitro

Annette Dalrymple, Tomasz Kostrzewski, Paloma Maraver, Sarah Corke, David Hughes, Marianna Gaca

Size 1 MB

Fully human in vitro gut-liver model of non-alcoholic steatohepatitis

Tomasz Kostrzewski, Paloma Maraver, Mohsen Shaeri, Sophie Snow, and David Hughes.

Size 953 KB

The PNPLA3 I148M variant enhances the disease phenotype of hepatic stellate cells in an in vitro model of non-alcoholic fatty liver disease

Tomasz Kostrzewski, Paloma Maraver, Ana Levi, Kareene Smith, Krista Rombouts and David Hughes

Size 1 MB

Microphysiological systems for studying interactions between the liver, gut and immune system

Tomasz Kostrzewski, Mohsen Shaeri, Larissa Ouro-Gnao, Sophie Snow, Kareene Smith, Paloma Maraver and David Hughes

Size 2 MB

Identification And Evaluation Of Patient Serum Isolates As A Source Of Inoculum For 3D In Vitro Cell Culture: A Tool For Drug Discovery

E. Large, C. Smith Burchnell, J. Malone, S. Snow, S. Wildum and D. Hughes

Size 321 KB

Three-dimensional perfused cell culture enhances the infectability of primary human hepatocytes with Hepatitis B virus

T. Kostrzewski, E. Large, C. Smith Burchnell, M. Shaeri, S. Snow, and D. Hughes

Size 289 KB

Three-dimensional human cell culture model for studying Non-Alcoholic Fatty Liver Disease

Tomasz Kostrzewski, Terri Cornforth, Mohsen Shaeri, Sophie Snow, Larissa Ouro and David Hughes

Size 442 KB

Investigating the PK/PD/efficacy relationship of PI3K inhibitors in vitro, enabled by a microfluidic addition and removal device

Dharaminder Singh, Paul Golby, Alysha Bray, Tomasz Kostrzewski, David Hughes

Size 1 MB

In vitro assessment of combination dosing regimens with in vivo like pharmacokinetic concentration profiles enabled by a microfluidic addition and removal device

Paul Golby, Dharaminder Singh, Edoardo Buffa, Tomasz Kostrzewski, David Hughes

Size 823 KB

Human organ
mimics

Powerful new
data

Translatable
results

COMPANY HEAD OFFICE INFORMATION:

332 Cambridge Science Park
Milton Road
Cambridge
CB4 0WN

+44 (0) 1223 737941
enquiries@cn-bio.com

FOR PRODUCT, SERVICES AND MARKETING ENQUIRIES:

+44 (0) 1223 737941
enquiries@cn-bio.com

CN BIO INNOVATIONS LIMITED REGISTERED OFFICE:

30 Upper High Street, Thame,
Oxfordshire, OX9 3EZ.

Registered No. 06517359.
VAT No. 978184563